01538nam a2200301Ia 4500001001200000003000800012006001900020007001500039008004100054020001500095040002100110035002000131050002500151245033900176260005800515300001800573504004100591533015200632610005300784650006600837650007300903650002000976650005100996655002901047710001701076856012601093999001701219ebr10060421CaPaEBRm        u        cr cn|||||||||040925s2004    dcu    gsb    000 0 eng d  z0309091721  aCaPaEBRcCaPaEBR  a(OCoLC)7077294114aR853.H8bI584 2004eb00aIntentional human dosing studies for EPA regulatory purposesh[electronic resource] :bscientific and ethical issues /cCommittee on the Use of Third Party Toxicity Research with Human Research Participants, Science, Technology, and Law Program, Policy and Global Affairs Division, National Research Council of the National Academies.  aWashington, D.C. :bNational Academies Press,cc2004.  axviii, 208 p.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries.10aUnited States.bEnvironmental Protection Agency. 0aHuman experimentation in medicinexMoral and ethical aspects. 0aHuman experimentation in medicinexGovernment policyzUnited States. 0aMedical ethics. 0aMedicinexResearchxMoral and ethical aspects. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10060421zAn electronic book accessible through the World Wide Web; click to view  c45983d45983